Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Steven Young-Min.

Newcastle AuthorsTitleYearFull text
Dr Jessica Tarn
Dr Nadia Howard-Tripp
Dr Dennis Lendrem
Andrew Skelton
Dr Katherine James
et al.
Symptom-based stratification of patients with primary Sjögren’s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials2019
Professor Fai Ng
Dr Katherine James
Dr Bridget Griffiths
Dr David Coady
Dr Steven Young-Min
et al.
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: Examination of data from the UK Primary Sjögren's Syndrome Registry2018
Dr Peter Gallagher
Sheryl Mitchell
Dr Bridget Griffiths
Vicki Hindmarsh
Ben Hargreaves
et al.
Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren’s Syndrome – Capturing the discrepancy2017
Sheryl Mitchell
Dr Katherine James
Professor Fai Ng
Dr Bridget Griffiths
Vicki Hindmarsh
et al.
Eligibility for clinical trials in primary Sjogren's syndrome: lessons from the UK Primary Sjogren's Syndrome Registry2016
Dr Jessica Tarn
Andini Natasari
Colin Gillespie
Sheryl Mitchell
Dr Katie Hackett
et al.
Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines2016
Dr Katherine James
Shereen Al-Ali
Dr Jessica Tarn
Dr Simon Cockell
Dr Colin Gillespie
et al.
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome2015
Professor Fai Ng
Dr Katherine James
Dr Bridget Griffiths
Dr James Andrews
Dr Vadivelu Saravanan
et al.
Eligibility for Clinical Trials in Primary Sjogren's Syndrome: Lessons from the UK Primary Sjogren's Registry2015
Mark Houseman
Dr Kate Potter
Nicola Marshall
Dr Rachel Lakey
Emeritus Professor Tim Cawston
et al.
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up2012
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Dr David Coady
Biomarkers in the prediction of radiographic progression in early rheumatoid arthritis: Comment on the article by Young-Min et al2008
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Dr David Coady
Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers2007
Dr Steven Young-Min
Dr Susan Hudson
Dr Clive Kelly
Gross synovial fluid analysis in the differential diagnosis of joint effusion2007
Dr Steven Young-Min
Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis2005
Dr Steven Young-Min
Dr David Coady
Emeritus Professor Tim Cawston
Are biochemical markers predictive of radiographic progression in early rheumatoid arthritis and do they perform better than traditional markers?2005
Dr Steven Young-Min
Dr David Coady
Sarah Charlton
Emeritus Professor Drew Rowan
Emeritus Professor Tim Cawston
et al.
Early rheumatoid arthritis patients with DR4 shared epitope alleles progress radiologically and have elevated levels of serum MMP-3, serum comp, urinary GLC-GAL-PYD and urinary collagen crosslinks2005
Dr Steven Young-Min
Dr David Coady
Emeritus Professor Tim Cawston
Longitudinal measurement of traditional observer and laboratory based markers enhances prediction of radiographic progression in early rheumatoid arthritis. patient based responses were of limited use2005
Dr David Coady
Dr Steven Young-Min
Dr Lesley Kay
Dr David Walker
Objective structured clinical examinations (OSCEs) of the musculoskeletal system who should be scoring them?2005
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Serum MMP-3 levels fall following the initiation of methotrexate in patients with early rheumatoid arthritis2005
Dr Steven Young-Min
Emeritus Professor Drew Rowan
Sarah Charlton
Dr David Coady
Emeritus Professor Tim Cawston
et al.
The biallelic 1G/2G single nucleotide polymorphism at position-1607BP of the MMP-1 promoter is not associated with rheumatoid arthritis, does not significantly affect measured levels of serum MMP-1 and is not associated with increased radiographic destruction2005
Dr Steven Young-Min
Emeritus Professor Tim Cawston
The dominant role of serum MMP-3 compared to serum MMP-1 and MMP-13 in the generation of breakdown products from joint tissues in patients with early rheumatoid arthritis2005
Dr Steven Young-Min
Dr John Fordham
Weekly alendronate-induced acute pseudogout [3]2005
Dr Steven Young-Min
What's new in Rheumatology2005
Dr Steven Young-Min
Copying clinic letters to patients will place additional demands on both secondary and primary care: A hospital outpatient questionnaire2004
Dr Steven Young-Min
Dr Bijayeswar Vaidya
CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy2004
Dr Steven Young-Min
Dr Vadivelu Saravanan
A survey of fibromyalgia in medical students2003
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Angela Grainger
Modified Larsen scoring of digitized radiographs in rheumatoid arthritis2003
Dr Bijayeswar Vaidya
Professor Simon Pearce
Stephen Charlton
Emeritus Professor Drew Rowan
Professor Pat Kendall-Taylor
et al.
An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies2002
Dr Steven Young-Min
Professor Simon Pearce
Dr Bijayeswar Vaidya
Re: An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies, by Vaidya et al. - Reply2002
Dr Steven Young-Min
Professor Simon Pearce
Dr Bijayeswar Vaidya
Reply Re: An association between the CTLA-4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies2002
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Leader: markers of joint destruction: principles, problems and potential2001
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Markers of joint destruction: principles, problems, and potential2001
Dr Steven Young-Min
Emeritus Professor Tim Cawston
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls2001